Advertisement
Advertisement
Traws Pharma Begins Phase 2 COVID-19 Treatment Study
PremiumCompany AnnouncementsTraws Pharma Begins Phase 2 COVID-19 Treatment Study
1M ago
Traws Pharma doses first patient with ratutrelvir in Phase 2 COVID studies
Premium
The Fly
Traws Pharma doses first patient with ratutrelvir in Phase 2 COVID studies
1M ago
Traws Pharma appoints John Leaman as independent director
Premium
The Fly
Traws Pharma appoints John Leaman as independent director
1M ago
Traws Pharma receives approval to proceed with Phase 2 COVID studies
PremiumThe FlyTraws Pharma receives approval to proceed with Phase 2 COVID studies
3M ago
Traws Pharma Advances Antiviral Programs Amid Revenue Growth
Premium
Company Announcements
Traws Pharma Advances Antiviral Programs Amid Revenue Growth
3M ago
Traws Pharma Reports Q2 2025 Financial Results
Premium
Company Announcements
Traws Pharma Reports Q2 2025 Financial Results
3M ago
Traws Pharma Publishes Promising Phase 2 Study Results
PremiumCompany AnnouncementsTraws Pharma Publishes Promising Phase 2 Study Results
5M ago
Traws Pharma publishes key efficacy data for rigosertib
Premium
The Fly
Traws Pharma publishes key efficacy data for rigosertib
5M ago
Traws Pharma Receives FDA Guidance on Flu Treatment
Premium
Company Announcements
Traws Pharma Receives FDA Guidance on Flu Treatment
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100